MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells

Human Molecular Genetics

Volumn 21, Issue 10, 2012, Pages 2157-2165

  Alvarez Díaz, Silvia ^a,e   Valle, Noelia ^a,f   Ferrer Mayorga, Gemma ^a   Lombardía, Luis ^b   Herrera, Mercedes ^c   Domínguez, Orlando ^b   Segura, Miguel F ^d   Bonilla, Félix ^c   Hernando, Eva ^d   Muñoz, Alberto ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CELL NUCLEUS RECEPTOR; MICRORNA 22; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; COLON CANCER; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; HNRPH1 GENE; HUMAN; HUMAN CELL; NELL2 GENE; NFAT5 GENE; OGN GENE; PRIORITY JOURNAL; RERE GENE; TRANSCRIPTION REGULATION; VITAMIN D DEFICIENCY;

CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICRORNAS;

EID: 84860459609     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds031     Document Type: Article

References (44)

1. Tuohimaa, P., Keisala, T., Minasyan, A., Cachat, J. and Kalueff, A. (2009) Vitamin D, nervous system and aging. Psychoneuroendocrinology, 34(Suppl. 1), S278-S286.
2. Norman, A.W. and Bouillon, R. (2010) Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med. (Maywood), 235, 1034-1045.
3. Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M.J., Mullie, P. and Autier, P. (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer, 128, 1414-1424.
4. Giovannucci, E. (2011) The epidemiology of vitamin D and cancer risk. In Feldman, D., Pike, J.W. and Adams, J.S. (eds), Vitamin D, 3rd edn. Elsevier-Academic Press, San Diego, CA, USA, Vol. 2, pp. 1569-1590.
5. Pálmer, H.G., González-Sancho, J.M., Espada, J., Berciano, M.T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A.G., Lafarga, M. et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signalling. J. Cell Biol., 154, 369-387.
6. González-Sancho, J.M., Larriba, M.J., Ordóñez-Morán, P., Pálmer, H.G. and Muñoz, A. (2006) Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res., 26, 2669-2681.
7. Deeb, K.K., Trump, D.L. and Johnson, C.S. (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer, 7, 684-700.
8. Carlberg, C. and Seuter, S. (2009) A genomic perspective on vitamin D signalling. Anticancer Res., 29, 3485-3493.
9. Carlberg, C. and Seuter, S. (2010) Dynamics of nuclear receptor target gene regulation. Chromosoma, 119, 479-484.
10. Álvarez-Díaz, S., Valle, N., García, J.M., Pea, C., Freije, J.M., Quesada, V., Astudillo, A., Bonilla, F., Lopez-Otín, C. and Muñoz, A. (2009) Cystatin D is a candidate tumour suppressor gene induced by vitamin D in human colon cancer cells. J. Clin. Invest., 119, 2343-2358.
11. Álvarez-Díaz, S., Larriba, M.J., Lopez-Otín, C. and Muñoz, A. (2010) Vitamin D: proteases, protease inhibitors and cancer. Cell Cycle, 9, 32-37.
12. Heikkinen, S., Vaisanen, S., Pehkonen, P., Seuter, S., Benes, V. and Carlberg, C. (2011) Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res., 39, 9181-9193.
13. Fabian, M.R., Sonenberg, N. and Filipowicz, W. (2010) Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem., 79, 351-379.
14. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet., 12, 861-874.
15. Kasinski, A.L. and Slack, F.J. (2011) MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer, 11, 849-864.
16. Zhang, J., Yang, Y., Yang, T., Liu, Y., Li, A., Fu, S., Wu, M., Pan, Z. and Zhou, W. (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer, 103, 1215-1220.
17. Xiong, J., Du, Q. and Liang, Z. (2010) Tumour-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene, 29, 4980-4988.
18. Patel, J.B., Appaiah, H.N., Burnett, R.M., Bhat-Nakshatri, P., Wang, G., Mehta, R., Badve, S., Thomson, M.J., Hammond, S., Steeg, P. et al. (2011) Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene, 30, 1290-1301.
19. Tsuchiya, N., Izumiya, M., Ogata-Kawata, H., Okamoto, K., Fujiwara, Y., Nakai, M., Okabe, A., Schetter, A.J., Bowman, E.D., Midorikawa, Y. et al. (2011) Tumour suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res., 71, 4628-4639.
20. Takata, A., Otsuka, M., Kojima, K., Yoshikawa, T., Kishikawa, T., Yoshida, H. and Koike, K. (2011) MicroRNA-22 and microRNA-140 suppress NF-kappaB activity by regulating the expression of NF-kappaB coactivators. Biochem. Biophys. Res. Commun., 411, 826-831.
21. Yamakuchi, M., Yagi, S., Ito, T. and Lowenstein, C.J. (2011) MicroRNA-22 regulates hypoxia signalling in colon cancer cells. PLoS ONE, 6, e20291.
22. Studzinski, G.P., Gocek, E. and Danilenko, M. (2011) Vitamin D effects on differentiation and cell cycle. In Feldman, D., Pike, J.W. and Adams, J.S. (eds), Vitamin D, 3rd edn. Elsevier-Academic Press, San Diego, CA, USA, vol. 2, pp. 1625-1656.
23. Mitsuhashi, T., Morris, R.C. Jr and Ives, H.E. (1991) 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J. Clin. Invest., 87, 1889-1895.
24. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
25. Pálmer, H.G., Sánchez-Carbayo, M., Ordóñez-Morán, P., Larriba, M.J., Cordón-Cardo, C. and Muñoz, A. (2003) Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res., 63, 7799-7806.
26. Ordóñez-Morán, P., Larriba, M.J., Pálmer, H.G., Valero, R.A., Barbáchano, A., Duñach, M., de Herreros, A.G., Villalobos, C., Berciano, M.T., Lafarga, M. et al. (2008) RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J. Cell Biol., 183, 697-710.
27. Peña, C., García, J.M., Silva, J., García, V., Rodríguez, R., Alonso, I., Millán, I., Salas, C., de Herreros, A.G., Muñoz, A. et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet., 14, 3361-3370.
28. Larriba, M.J., Martín-Villar, E., García, J.M., Pereira, F., Peña, C., de Herreros, A.G., Bonilla, F. and Muñoz, A. (2009) Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis, 30, 1459-1468.
29. Pálmer, H.G., Larriba, M.J., García, J.M., Ordóñez-Morán, P., Peña, C., Peiró, S., Puig, I., Rodríguez, R., de la Fuente, R., Bernad, A. et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med., 10, 917-919.
30. Bai, J., Sata, N., Nagai, H., Wada, T., Yoshida, K., Mano, H., Sata, F. and Kishi, R. (2004) Genistein-induced changes in gene expression in Panc 1 cells at physiological concentrations of genistein. Pancreas, 29, 93-98.
31. Kuroda, S., Oyasu, M., Kawakami, M., Kanayama, N., Tanizawa, K., Saito, N., Abe, T., Matsuhashi, S. and Ting, K. (1999) Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem. Biophys. Res. Commun., 265, 79-86.
32. Maeda, K., Matsuhashi, S., Tabuchi, K., Watanabe, T., Katagiri, T., Oyasu, M., Saito, N. and Kuroda, S. (2001) Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumours. Neurol. Med. Chir. (Tokyo), 41, 582-588; discussion 589.
33. Luo, J., Dunn, T.A., Ewing, C.M., Walsh, P.C. and Isaacs, W.B. (2003) Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. Prostate, 57, 134-139.
34. Choi, E.J., Kim, D.H., Kim, J.G., Kim, D.Y., Kim, J.D., Seol, O.J., Jeong, C.S., Park, J.W., Choi, M.Y., Kang, S.G. et al. (2010) Estrogen-dependent transcription of the NEL-like 2 (NELL2) gene and its role in protection from cell death. J. Biol. Chem., 285, 25074-25084.
35. Rauch, J., O'Neill, E., Mack, B., Matthias, C., Munz, M., Kolch, W. and Gires, O. (2010) Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res., 70, 1679-1688.
36. Hope, N.R. and Murray, G.I. (2011) The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum. Pathol., 42, 393-402.
37. Stark, M., Bram, E.E., Akerman, M., Mandel-Gutfreund, Y. and Assaraf, Y.G. (2011) Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance. J. Biol. Chem., 286, 3741-3754.
38. Jauliac, S., Lopez-Rodriguez, C., Shaw, L.M., Brown, L.F., Rao, A. and Toker, A. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol., 4, 540-544.
39. Chen, M., Sastry, S.K. and O'Connor, K.L. (2011) Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells. Am. J. Physiol. Cell Physiol., 300, C1155-C1163.
40. Levy, C., Khaled, M., Iliopoulos, D., Janas, M.M., Schubert, S., Pinner, S., Chen, P.H., Li, S., Fletcher, A.L., Yokoyama, S. et al. (2010) Intronic miR-211 assumes the tumour suppressive function of its host gene in melanoma. Mol. Cell, 40, 841-849.
41. Wang, L. and Tsai, C.C. (2008) Atrophin proteins: an overview of a new class of nuclear receptor corepressors. Nucl. Recept. Signal., 6, e009.
42. Cui, X.N., Tang, J.W., Song, B., Wang, B., Chen, S.Y. and Hou, L. (2009) High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells. World. J. Gastroenterol., 15, 6117-6122.
43. Wang, W.L., Chatterjee, N., Chittur, S.V., Welsh, J. and Tenniswood, M.P. (2011) Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer, 10, 58.
44. Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M. et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques, 34, 374-378.